Blessing Ja

560 total citations
17 papers, 421 citations indexed

About

Blessing Ja is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Blessing Ja has authored 17 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 9 papers in Obstetrics and Gynecology and 4 papers in Oncology. Recurrent topics in Blessing Ja's work include Ovarian cancer diagnosis and treatment (12 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Uterine Myomas and Treatments (4 papers). Blessing Ja is often cited by papers focused on Ovarian cancer diagnosis and treatment (12 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Uterine Myomas and Treatments (4 papers). Blessing Ja collaborates with scholars based in United States. Blessing Ja's co-authors include Charles E. Mangan, Buchsbaum Hj, DiSaia Pj, Creasman Wt, Tate Thigpen, B. Bundy, M. Berman, Cynthia Angel, Wallace Hj and M Slavík and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Blessing Ja

17 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Blessing Ja United States	11	298	221	118	105	91	17	421
Gordon O. Downey United States	9	249 0.8×	159 0.7×	88 0.7×	62 0.6×	65 0.7×	17	350
David L. Marchetti United States	12	138 0.5×	171 0.8×	68 0.6×	54 0.5×	75 0.8×	12	293
Kevin L. Hall United States	10	165 0.6×	127 0.6×	78 0.7×	58 0.6×	61 0.7×	16	325
H.W.H.M. van der Putten Netherlands	11	228 0.8×	166 0.8×	61 0.5×	29 0.3×	101 1.1×	16	406
Allan J. Jacobs United States	9	139 0.5×	180 0.8×	100 0.8×	31 0.3×	59 0.6×	19	321
J.T. Chambers United States	10	205 0.7×	221 1.0×	60 0.5×	38 0.4×	49 0.5×	23	358
Boyes Da	7	122 0.4×	224 1.0×	125 1.1×	38 0.4×	69 0.8×	18	342
M.P. Hopkins United States	5	283 0.9×	101 0.5×	212 1.8×	52 0.5×	136 1.5×	9	390
Jennifer Ducie United States	13	436 1.5×	409 1.9×	54 0.5×	62 0.6×	81 0.9×	16	630
Giuseppa Maltese Italy	11	203 0.7×	215 1.0×	84 0.7×	85 0.8×	115 1.3×	25	394

Countries citing papers authored by Blessing Ja

Since Specialization

Citations

This map shows the geographic impact of Blessing Ja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blessing Ja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blessing Ja more than expected).

Fields of papers citing papers by Blessing Ja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blessing Ja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blessing Ja. The network helps show where Blessing Ja may publish in the future.

Co-authorship network of co-authors of Blessing Ja

This figure shows the co-authorship network connecting the top 25 collaborators of Blessing Ja. A scholar is included among the top collaborators of Blessing Ja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blessing Ja. Blessing Ja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ja, Blessing, et al.. (1987). Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study.. PubMed. 71(9). 869–70. 4 indexed citations

Ja, Blessing, et al.. (1987). Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.. PubMed. 71(6). 661–2. 21 indexed citations

Ja, Blessing, et al.. (1987). Phase II trial of etoposide in the management of advanced and recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study.. PubMed. 71(12). 1303–4. 27 indexed citations

Ja, Blessing, et al.. (1986). Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.. PubMed. 70(2). 271–4. 60 indexed citations

Ja, Blessing, et al.. (1986). Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.. PubMed. 70(2). 309–10. 3 indexed citations

Thigpen, Tate & Blessing Ja. (1985). Current therapy of ovarian carcinoma: an overview.. PubMed. 12(3 Suppl 4). 47–52. 23 indexed citations

Ja, Blessing, et al.. (1984). Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study.. PubMed. 68(2). 439–40. 2 indexed citations

Ja, Blessing, et al.. (1984). Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.. PubMed. 68(12). 1513–4. 12 indexed citations

Slavík, M, et al.. (1984). Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study.. PubMed. 68(5). 809–11. 26 indexed citations

10.

Slavík, M, Hyman B. Muss, & Blessing Ja. (1983). Phase II clinical study of Yoshi 864 in squamous cell carcinoma of the uterine cervix.. PubMed. 67(2). 195–6. 2 indexed citations

11.

Bonomi, P., et al.. (1983). Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.. PubMed. 67(2). 197–8. 4 indexed citations

12.

Ja, Blessing, et al.. (1982). Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.. PubMed. 66(8). 1669–71. 16 indexed citations

13.

Wt, Creasman, et al.. (1980). Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.. PubMed. 63(11-12). 2089–92. 39 indexed citations

14.

Hj, Buchsbaum, et al.. (1979). Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.. PubMed. 63(1). 21–7. 115 indexed citations

15.

Wt, Creasman, et al.. (1979). Chemoimmunotherapy in the management of primary stage III ovarian cancer: a Gynecologic Oncology Group study.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(2). 319–23. 10 indexed citations

16.

Hj, Wallace, et al.. (1978). Comparison of the therapeutic effects of adriamycin alone versus adriamycin plus vincristine versus adriamycin plus cyclophosphamide in the treatment of advanced carcinoma of the cervix.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(10). 1435–41. 39 indexed citations

17.

Wt, Creasman, et al.. (1978). Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.. PubMed. 62(5). 833–5. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact